Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Guidelines on Developing Consumer Information on Proper Use of Traditional, Complementary and Alternative Medicine
(2004; 109 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentForeword
View the documentPreface
View the documentGlossary
Open this folder and view contents1. General Considerations
Open this folder and view contents2. Development of Consumer Information
Open this folder and view contents3. General Principles and Activities for Ensuring Reliable TM/CAM Information
Open this folder and view contents4. Topics to Consider when Developing Consumer Information Promoting Proper Use of TM/CAM
View the document5. Use of this Publication
View the documentReferences
Open this folder and view contentsAnnexes
View the documentBack Cover
 

References

1. The importance of pharmacovigilance: safety monitoring of medicinal plants. Geneva, WHO, 2002.

2. WHO Traditional Medicine Strategy 2002-2005. Geneva, WHO, 2002 (document reference WHO/EDM/TRM/2002.1).

3. General guidelines for methodologies on research and evaluation of traditional medicine. Geneva, WHO, 2000 (document reference WHO/EDM/TRM/2000.1).

4. Ernst E. Prevalence of the use of complementary/alternative medicine: a systematic review. Bulletin of the World Health Organization, 2000, 78:252-257.

5. Brieger WR et al. Roll Back Malaria. Pre-testing of needs assessment procedures. IDO Local government, Oyo State Nigeria. Unpublished draft, 1998.

6. Diarria D et al. Roll Back Malaria. Needs assessment report. Field test of instruments and methodology in Mali. Unpublished draft, 1999; copy available from Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization.

7. Gyapong M, Aikins M, Amofah G. Report on pretesting of instruments of roll back malaria needs assessment in the Dangme West District Ghana. Unpublished draft, 1999; copy available from Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization.

8. RBM Country Team. The final RBM Report on the pre-testing of the RBM (WHO) research instruments, and the situation analysis for action again malaria in Petauke District, Zambia (21st December 1998 to 20th January 1999). Unpublished draft, 1999; copy available from Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization.

9. Vickers A. Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. Journal of the Royal Society of Medicine, 1996, 89:303-311.

10. Ernst E, Pittler MH. The effectiveness of acupuncture in treating acute dental pain: a systematic review. British Dental Journal, 1998, 184:443-447.

11. Linde K, Mulrow CD. St John’s Wort for depression. On-line Cochrane Library Issue 4, 2 November 2002.

12. Wilt T, Ishani A, MacDonald R. Serenoa Repens for benign prostatic hyperplasia. On-line Cochrane Library Issue 4, 2 November 2002.

13. NIH News Release - NIH Panel Issue. NIH Panel Issues Consensus Statement on Acupuncture, Bethesda, Maryland, National Institutes of Health, 1997 (available on the Internet at http://www.nih.gov/news/pr/nov97/od-05.html, accessed 20 May 2004).

14. Carlsson M et al. Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nursing, 2001, 24:395-401.

15. Power R et al. HIV: Effectiveness of Complementary and Alternative Medicine. Primary Care, 2002, 29:361-78.

16. Collaboration with Traditional Healers in AIDS Prevention and Care in Sub-Saharan Africa: a literature review. Geneva, UNAIDS, 2000.

17. Ernst E. The desktop guide to complementary and alternative medicine: An evidence based approach. Orlando, FL, Harcourt Ltd, 2001.

18. Huang WF, Wen KC, Hsaio ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. Journal of Clinical Pharmacology, 1997, 37:334-350.

19. Ko R. Adulterant in Asian patent medicines. New England Journal of Medicine, 1998, 339; 847:12.

20. Farah M et al. International monitoring of adverse events associated with herbal medicines. Pharmacoepidemiology and Drug Safety, 2000, 9:105-112.

21. Uppsala Monitoring Center (Internet communication of 1 November 2002 at web site http://www.who-umc.org).

22. Ang-Lee M, Moss J, Yuan C. Herbal medicine and perioperative Care. The Journal of the American Medical Association, 2001, 286:208-216.

23. Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety, 2002, 25: 251-261.

24. Fugh-Berman H. Herb-drug interactions, Lancet, 2000, 355: 134-138.

25. WHO Monographs on Selected Medicinal Plants Volume 1. Geneva, WHO, 1999.

26. WHO Monographs on Selected Medicinal Plants Volume 2. Geneva, WHO, 2002.

27. Eisenberg D et al. Trends in alternative medicine use in the United States, 1990-1997. The Journal of the American Medical Association, 1998, 280:1569-1575.

28. Falkenberg T. Towards a global atlas of traditional/complementary and alternative medicine utilization: Provisional indicators for monitoring traditional, complementary and alternative medicine use. In: Proceedings of WKC International Consultative Meeting Global Information on Traditional Medicine/Complementary and Alternative Medicine Practices and Utilization, WHO Collaborating Centre, Kobe, Japan, 19-21 September 2001.

29. Quality control methods for medicinal plant materials. Geneva, WHO, 1998.

30. Acupuncture: Review and analysis of reports on controlled clinical trials. Geneva, WHO, 2002.

31. Zollman C, Vickers A. ABC of complementary medicine. London, BMJ Books, 2000.

32. Guidelines on basic training and safety in acupuncture. Geneva, WHO, 1999 (document reference WHO/EDM/TRM/99.1).

33. Complementary and Alternative Medicine, Session 1999-2000, 6th report, House of Lords Select Committee on Science and Technology. London, Stationery Office, 2000 (available on the Internet at http://www.parliament.the-stationery-office.co.uk/pa/ld199900/ldselect/ldsctech/123/12301.htm, accessed 20 May 2004).

34. Chan T. Incidence of herb-induced aconitine poisoning in Hong-Kong: Impact of publicity measures to promote awareness among the herbalists and the public. Drug Safety, 2002, 25:823-828.

35. Public education in rational drug use: A global survey. Geneva, WHO, 1997 (document reference WHO/DAP/97.5).

36. Perspective on complementary and alternative medicine: A collection of papers prepared for Health Canada, Health Canada, 2001 (available on the Internet at http://www.hc-sc.gc.ca/healthcare/cahc/index.html, accessed 20 May 2004).

37. McCarthy M. US Panel calls for more support of alternative medicine. Lancet, 359:1213.

38. Guidelines on the safety monitoring and pharmacovigilance of herbal medicines. Geneva, WHO, in preparation.

39. Gandelsonas C. Communicating for development: Experience from the urban environment. London, ITDG Publishing, 2002.

40. Guiding principles in self-medication. Ferney Voltaire, France, World Self-Medication Industry (WSMI), 2002 (document originally found at http://www.wsmi.org/).

41. The DISCERN handbook: quality criteria for consumer health information on treatment choices. Abingdon, Radcliffe Medical Press, 1998.

42. Medical products and the Internet: A guide to finding reliable information. Geneva, WHO, 1999 (document reference WHO/EDM/QSM/99.4).

43. Legal status of traditional medicine and complementary and alternative medicine: A worldwide review. Geneva, WHO, 2001 (document reference WHO/EDM/TRM/2001.2).

44. Regulatory situation of herbal medicines: A worldwide review. Geneva, WHO, 1998 (document reference WHO/TRM/98.1). 45. Guidelines for the assessment of herbal medicines. Geneva, WHO, 1991 (document reference WHO/TRM/91.4)

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014